Kingworld Medicines Group Ltd. (1110) Financial Statements

0 Followers

Kingworld Medicines Group Ltd. Financial Overview

Kingworld Medicines Group Ltd.'s market cap is currently HK$288.09M. The company's EPS TTM is HK$0.0164; its P/E ratio is 4.42; and it has a dividend yield of 5.87%. Kingworld Medicines Group Ltd. is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 893.60M	¥ 1.06B	¥ 1.08B	¥ 957.70M	¥ 847.39M
Gross Profit	¥ 241.49M	¥ 270.45M	¥ 280.67M	¥ 277.63M	¥ 263.60M
Operating Income	¥ 47.85M	¥ 89.70M	¥ 96.81M	¥ 72.23M	¥ 72.22M
EBITDA	¥ 73.17M	¥ 100.46M	¥ 125.48M	¥ 118.07M	¥ 116.00M
Net Income	¥ 10.99M	¥ 41.56M	¥ 38.10M	¥ 22.74M	¥ 30.32M
Balance Sheet
Cash & Short-Term Investments	¥ 274.70M	¥ 249.60M	¥ 194.03M	¥ 256.17M	¥ 198.41M
Total Assets	¥ 1.44B	¥ 1.42B	¥ 1.34B	¥ 1.26B	¥ 1.21B
Total Debt	¥ 434.05M	¥ 402.44M	¥ 354.43M	¥ 290.68M	¥ 238.96M
Net Debt	¥ 169.53M	¥ 167.14M	¥ 180.75M	¥ 48.52M	¥ 51.03M
Total Liabilities	¥ 753.86M	¥ 710.04M	¥ 638.30M	¥ 569.15M	¥ 493.19M
Stockholders' Equity	¥ 617.97M	¥ 639.79M	¥ 619.03M	¥ 615.58M	¥ 616.90M
Cash Flow
Free Cash Flow	¥ 54.92M	¥ 94.73M	¥ -63.25M	¥ 93.64M	¥ 22.88M
Operating Cash Flow	¥ 84.56M	¥ 135.82M	¥ 42.28M	¥ 186.55M	¥ 81.20M
Investing Cash Flow	¥ -20.11M	¥ -27.64M	¥ -120.63M	¥ -84.05M	¥ -50.84M
Financing Cash Flow	¥ -30.82M	¥ -47.61M	¥ 4.37M	¥ -51.31M	¥ -87.20M

Currency in CNY

Kingworld Medicines Group Ltd. Earnings and Revenue History

Income Statement >

Kingworld Medicines Group Ltd. Debt to Assets

Balance Sheet >

Kingworld Medicines Group Ltd. Cash Flow

Cash Flow >

Kingworld Medicines Group Ltd. Forecast EPS vs Actual EPS

Earnings >